Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre, Randomized, Placebo-Controlled, Efficacy Study of Prebiotic Galacto-oligosaccharides on Gastrointestinal Symptom Severity in Patients With Irritable Bowel Syndrome

NCT05157061 is registered in ClinicalTrials.gov with Clasado as lead sponsor.

NCT NCT05157061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05157061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre, Randomized, Placebo-Controlled, Efficacy Study of Prebiotic Galacto-oligosaccharides on Gastrointestinal Symptom Severity in Patients With Irritable Bowel Syndrome
Lead sponsor
Clasado
Phase
Not applicable
Overall status
Completed
Start date
October 26, 2021
Completion date
August 6, 2024
Enrollment
153 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome, irritable bowel syndrome - constipation, irritable bowel syndrome - diarrhoea, irritable bowel syndrome - mixed